ValueInvest Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$106M Buy
2,035,667
+167,680
+9% +$9.06M 7.2% 7
2017
Q4
$100M Buy
1,867,987
+264,411
+16% +$14.7M 6.2% 8
2017
Q3
$98M Sell
1,603,576
-79,963
-5% -$4.85M 6.53% 8
2017
Q2
$103M Sell
1,683,539
-31,754
-2% -$1.93M 6.36% 9
2017
Q1
$104M Sell
1,715,293
-466,674
-21% -$28.3M 6.31% 9
2016
Q4
$123M Buy
+2,181,967
New +$128M 7.37% 7

Other funds holding MRK

ValueInvest Asset Management's MRK Position: Q1 2018 in Review

ValueInvest Asset Management increased its Merck (MRK) stake by 9% in Q1 2018, buying an estimated $9.06M and bringing the position to 2,035,667 shares worth $106M. The position accounts for 7.2% of the portfolio, ranked #7.

ValueInvest Asset Management first reported a position in MRK in Q4 2016 and has held it in 6 quarters since. The position peaked at $123M in Q4 2016. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • ValueInvest Asset Management held 2,035,667 shares of Merck worth $106M as of Q1 2018.
  • ValueInvest Asset Management bought 167,680 Merck shares in Q1 2018, an estimated $9.06M.
  • Merck made up 7.2% of ValueInvest Asset Management's portfolio in Q1 2018, its #7 holding.
  • ValueInvest Asset Management first reported a position in Merck in Q4 2016 and has held it in 6 quarters since.
  • ValueInvest Asset Management's Merck position peaked at $123M in Q4 2016.
  • 1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on ValueInvest Asset Management's 13F filing for Q1 2018, filed 9 May 2018.